ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

ClinicalTrials.gov ID: NCT03502616

Public ClinicalTrials.gov record NCT03502616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY OF THE EFFICACY AND SAFETY OF TOFACITINIB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS (AS)

Study identification

NCT ID
NCT03502616
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

  • Tofacitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2018
Primary completion
Dec 18, 2019
Completion
Aug 19, 2020
Last update posted
Sep 16, 2021

2018 – 2020

United States locations

U.S. sites
28
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801
Arizona Arthritis & Rheumatology Associates, P.C. Gilbert Arizona 85297
Medvin Clinical Research Covina California 91722
Rheumatology Center of San Diego PC San Diego California 92128
University of California, San Francisco Medical Center San Francisco California 94143
Robin K. Dore, MD, Inc. Tustin California 92780
New England Research Associates, LLC Bridgeport Connecticut 06606
Advanced Radiology Stamford Connecticut 06902
Stamford Therapeutics Consortium Stamford Connecticut 06905
Southcoast Research Center, Inc. Miami Florida 33136
Millennium Research Ormond Beach Florida 32174
Bluegrass Community Research, Inc Lexington Kentucky 40504
Center for Rheumatology and Bone Research Wheaton Maryland 20902
M3-Emerging Medical Research, LLC Durham North Carolina 27704
Paramount Medical Research and Consulting, LLC Middleburg Heights Ohio 44130
Oregon Health & Science University Portland Oregon 97239
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology Summerville South Carolina 29486
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034
Adriana Pop-Moody MD - Clinic PA Corpus Christi Texas 78404
Metroplex Clinical Research Center Dallas Texas 75231
Clinical Research Unit Houston Texas 77030
Investigational Drug Services Houston Texas 77030
Memorial Hermann Hospital Imaging Houston Texas 77030
Southwest Rheumatology Research LLC Mesquite Texas 75150
Trinity Universal Research Associates, Inc. Plano Texas 75024
Advanced Rheumatology of Houston The Woodlands Texas 77382
Arthritis Northwest, PLLC Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03502616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2021 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03502616 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →